| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.1 |